JP2022535955A5 - - Google Patents

Info

Publication number
JP2022535955A5
JP2022535955A5 JP2021573380A JP2021573380A JP2022535955A5 JP 2022535955 A5 JP2022535955 A5 JP 2022535955A5 JP 2021573380 A JP2021573380 A JP 2021573380A JP 2021573380 A JP2021573380 A JP 2021573380A JP 2022535955 A5 JP2022535955 A5 JP 2022535955A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
disease
substituted
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021573380A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535955A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/066196 external-priority patent/WO2020249669A1/en
Publication of JP2022535955A publication Critical patent/JP2022535955A/ja
Publication of JP2022535955A5 publication Critical patent/JP2022535955A5/ja
Pending legal-status Critical Current

Links

JP2021573380A 2019-06-12 2020-06-11 スルホンアミド誘導体及びその使用 Pending JP2022535955A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962860661P 2019-06-12 2019-06-12
US62/860,661 2019-06-12
PCT/EP2020/066196 WO2020249669A1 (en) 2019-06-12 2020-06-11 Sulfonamide derivatives and uses thereof

Publications (2)

Publication Number Publication Date
JP2022535955A JP2022535955A (ja) 2022-08-10
JP2022535955A5 true JP2022535955A5 (enExample) 2023-06-19

Family

ID=71108564

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573380A Pending JP2022535955A (ja) 2019-06-12 2020-06-11 スルホンアミド誘導体及びその使用

Country Status (5)

Country Link
US (1) US20220267300A1 (enExample)
EP (1) EP3983388A1 (enExample)
JP (1) JP2022535955A (enExample)
CN (1) CN114761383A (enExample)
WO (1) WO2020249669A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
CN114641466B (zh) 2019-06-12 2025-09-30 诺瑟拉有限公司 磺酰脲衍生物及其用途
EP4559461A1 (en) * 2023-11-22 2025-05-28 Servicio Andaluz De Salud Dual nlrp1 and nlrp3 inhibitors for use as a medicament

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903210A (en) * 1970-02-03 1972-06-20 Merck Sharp And Dohme (I.A.) Corp. Indole derivatives
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
WO1993004045A1 (en) * 1991-08-19 1993-03-04 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazolinone derivatives
AU2494792A (en) * 1991-08-19 1993-03-16 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazolinone derivatives
NZ247440A (en) * 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
AU7782694A (en) * 1993-09-28 1995-04-18 Ciba-Geigy Ag Acylated sulphonamides as insecticides and acaricides
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
PE20040167A1 (es) * 2002-03-28 2004-05-26 Novartis Ag Amidas del acido sulfamico
KR102727059B1 (ko) * 2015-02-16 2024-11-05 더 유니버서티 어브 퀸슬랜드 설포닐우레아와 관련 화합물 및 그 용도
RU2724345C2 (ru) * 2015-10-09 2020-06-23 Галапагос Нв N-СУЛЬФОНИЛИРОВАННЫЕ ПИРАЗОЛО[3,4-b]ПИРИДИН-6-КАРБОКСАМИДЫ И СПОСОБ ИХ ПРИМЕНЕНИЯ
CN109071454B (zh) * 2016-02-16 2023-02-17 昆士兰大学 磺酰脲和相关化合物及其用途
ES2940611T3 (es) * 2016-04-18 2023-05-09 Novartis Ag Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP
EP3272739A1 (en) * 2016-07-20 2018-01-24 NodThera Limited Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
EP3634951B8 (en) * 2017-06-09 2024-08-21 Zydus Lifesciences Limited Novel substituted sulfoximine compounds
GB201721185D0 (en) * 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
GB201902327D0 (en) * 2019-02-20 2019-04-03 Inflazome Ltd Novel compounds
US12187702B2 (en) * 2018-08-15 2025-01-07 Inflazome Limited Sulfonamideurea compounds

Similar Documents

Publication Publication Date Title
JP2022535955A5 (enExample)
US20220169628A1 (en) Therapeutic agents and methods of treatment
JP6125614B2 (ja) ピロロベンゾジアゼピン
CN112105360B (zh) 用于癌症治疗的bcl-2蛋白降解剂
ES2905318T3 (es) Profármacos de riluzol y su uso
JP2023540733A5 (enExample)
JP2022536160A5 (enExample)
JP2021522276A5 (enExample)
FI3728238T3 (fi) Sulfonyyliureajohdannaisia nlrp3-inflammasomin moduulaattoreina
JP2018531289A5 (enExample)
RU2018105549A (ru) Производные бензодиазепина как ингибиторы rsv
JP2004516278A (ja) 一酸化窒素合成酵素阻害物質であるリン酸塩
JP2022507506A5 (enExample)
WO2013138753A1 (en) Prodrugs of riluzole and their method of use
CN102036956A (zh) 取代的吡咯烷和哌啶化合物、它们的衍生物、以及用于治疗疼痛的方法
JP2022535956A5 (enExample)
HRP20240896T1 (hr) Derivati sulfoniluree i njihova upotreba
JP2023500662A (ja) イタコネートおよびメチルイタコネートの新規プロドラッグ
JP2022518526A5 (enExample)
KR102388412B1 (ko) 페노티아진 유도체 및 이의 사용 방법
JP2025504374A5 (enExample)
US8871983B2 (en) Lipid compounds for suppression of tumorigenesis
EP4514786A1 (en) Sting agonists, formulations, and uses thereof
RU2023108168A (ru) Производные сульфамоилмочевины, содержащие алкилоксациклоалкильную группу, и их применения
US20130296348A1 (en) Bis-Quinazoline Derivatives as Inhibitors for Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase